U.S. Computed Tomography (CT) Scanners Market Size, Share & Industry Analysis, By Technology (High Slice, Mid Slice, Low Slice, and Cone Beam Computed Tomography (CBCT)), By Application (Orthopedics, Cardiovascular, Oncology, Neurology, and Others), By Modality (O-arms and C-arms), By End-User (Hospitals & Ambulatory Surgical Centers (ASCs), Diagnostic Imaging Centers, and Others), and Country Forecast, 2024-2032

The U.S. Computed Tomography (CT) scanners market size was worth USD 1.85 billion in 2023 and is projected to grow at a CAGR of 5.5% during the forecast period. 

The number of patients undergoing computed tomography scans in the country. A few factors attributed to this increase in imaging procedures include rising prevalence of chronic conditions, increasing awareness towards early diagnosis, and a well-established healthcare infrastructure in the U.S. This along with the increased demand for technological advancements in imaging systems for primary diagnosis and imaging of patients across healthcare settings, are driving the growth of the market.

• According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) estimates in September 2022, more than 200.0 million people suffer from chronic obstructive pulmonary disease in the U.S.

The COVID-19 pandemic had a positive impact on the market in 2020. This was due to higher clinical efficiency of these systems for diagnosis and management of patients suffering from coronavirus.

LATEST TRENDS 

Rising Launch of Technologically Advanced Systems by Key Players

The use of computed tomography (CT) scanners for medical imaging has significantly improved disease diagnosis among patients. Thus, market players are focusing on R&D to develop technologically advanced solutions specific to certain applications, such as cardiology and neurology.

• In November 2022, Fujifilm Corporation announced the U.S. launch of the Scenaria View Focus Edition system, a scanner with an advanced Cardiac Motion Correction features. The system is designed for advanced clinical applications, including interventional CT, coronary computed tomography angiography (CCTA), extended coverage for scanning of perfusion, and dual-energy examinations.

Thus, the rising introduction of CT systems by key players across the country boosts the adoption of these devices across hospitals and diagnostic centers, stimulating market growth.

DRIVING FACTORS

Increasing Emphasis on Early Disease Diagnosis to Propel Market Growth

A large patient pool is undergoing imaging procedures owing to rising prevalence of chronic diseases, and increasing awareness among general population towards early diagnosis. This is anticipated to spur the demand for these systems across healthcare systems during the forecast period.

• As per July 2021 NeuroLogica Corp. statistics, around 80.0 million computed tomography scans are performed in the U.S. every year.

The increasing demand for early-stage diagnosis of chronic diseases among the U.S. population and the developed healthcare infrastructure in the country are the major factors responsible for the growing demand for CT scanners. This is anticipated to propel the U.S. Computed Tomography scanners market growth.

RESTRAINING FACTORS

Request a Free sample to learn more about this report.

High Installation Costs of Computed Tomography Scanners to Limit the Demand for These Systems 

The adoption of new computed tomography scanners in the U.S. is hampered due to the high maintenance and installation costs. Moreover, the high annual maintenance cost of these systems makes it challenging for small and mid-sized healthcare facilities to install these systems.

• According to a June 2023 article by Excedr, a 128+ slice computed tomography system's estimated acquisition cost is USD 0.7 million to USD 1.0 million. However, as per similar statistics, a refurbished 128+ slice CT scanner can cost about USD 0.2 million to USD 0.6 million. This has led to the entry of domestic players into a lucrative segment of refurbished equipment to offer these systems at affordable prices to healthcare facilities in the country.

Thus, the high installation cost of these systems across healthcare facilities and the rising preference for refurbished products over new products may hinder the U.S. market growth during the forecast period.

SEGMENTATION

By Technology Analysis

Based on technology, the market is segmented into low slice, mid slice, high slice, and cone beam computed tomography (CBCT).

The low slice segment held a dominant market share in 2022. This was primarily driven by new product launches in the U.S. market and low pricing compared to high-end devices. However, gradually rising demand for high-end computed tomography scanners in the U.S., especially from large hospitals, is anticipated to drive the growth of the high slice segment during the forecast period. This is further augmented by the rising focus on R&D by market players aiming to introduce high-end systems in the U.S.

By Application Analysis 

In terms of application, the market is segmented into neurology, cardiovascular, oncology, orthopedics and others.

The oncology segment dominated the market in 2022 owing to the increasing prevalence of cancer in the country. Additional factor propelling industry expansion is the rising adoption of computed tomography scanners in cancer diagnostics and to detect tumors and other cancer-related abnormalities.

• According to data published by the American Cancer Society, Inc., in 2022, an estimated 1.9 million cancer cases were diagnosed in the U.S.

By Modality Analysis 

Based on modality, the market is segmented into the o-arms and c-arms.

The o-arms segment held the largest market share in 2022 and was attributed to the rising emphasis of key players on introducing new o-arm systems, and high adoption of these devices among healthcare professionals in the U.S.

• In April 2021, Hitachi, Ltd. launched the Scenaria 64-slice computed tomography system. The new system works on dose reduction technology, and caters to aid the interventional radiologists in their practice.

By End-User Analysis 

Based on end-user, the market is classified into diagnostic imaging centers, hospitals and ambulatory surgical centers (ASCs), and others.

The hospitals and ambulatory surgical centers (ASCs) segment dominated the market in 2022. This is owing to an increasing number of computed tomography imaging examinations at hospitals and ambulatory surgical centers (ASCs) across the country.

• For instance, as per OECD statistics in 2021, around 68.5 million computed tomography scans were performed in U.S. hospitals, compared to 58.7 million in 2020.

KEY INDUSTRY PLAYERS

Strong Distribution Network of Major Players Propelled U.S. Market Share

The U.S. market is saturated by a few major players, such as Koninklijke Philips N.V., Canon Medical Systems Corporation, GE HealthCare, and Siemens Healthineers AG. Several factors, such as the presence of diversified portfolio of imaging systems, and an extensive distribution network in the U.S., have augmented the strong foothold of these players in the market.

Other key players such as Neusoft Corporation, Hitachi, Ltd., Carestream Health, and Fujifilm Corporation, focus on inorganic strategies to introduce innovative and technologically advanced systems, further increasing their scanners market share.

• In July 2021, Fujifilm Corporation acquired Hitachi, Ltd.’s diagnostic imaging-related business. Through this acquisition, Fujifilm Corporation aimed to expand its diagnostics business in the U.S. and other geographies and offer comprehensive solutions that cater to a broad range of clinical needs.

LIST OF KEY COMPANIES PROFILED:

• GE Healthcare (U.S.)


• Siemens Healthineers AG (Germany)


• Koninklijke Philips N.V. (Netherlands)


• Neusoft Corporation (China)


• Canon Medical Systems Corporation (Japan)


• Carestream Health (U.S.)


• Planmeca Oy (Finland)


• Fujifilm Corporation (Japan)


• NeuroLogica Corp. (U.S.)

KEY INDUSTRY DEVELOPMENTS:

• April 2023 - Kromek Group plc, a Sedgefield-based detection technology developer, entered an agreement with a U.S.-based Analogic Corporation to develop Photon Counting Computed Tomography (PCCT) applications in the medical imaging and security sectors.


• November 2021- GE HealthCare collaborated with Karolinska Institutet & MedTechLabs with an aim to clinically evaluate its patented silicon-based photon counting CT system. The development represents the company’s focus toward continuous innovation to bring novel technologies to the market.


• September 2021- GE HealthCare launched a new CT scanner, Revolution Ascend. The product increased operational efficiency and helped clinicians deliver personalized care to patients.

REPORT COVERAGE

An Infographic Representation of U.S. Computed Tomography (CT) Scanners Marke

View Full Infographic

To get information on various segments, share your queries with us

The market research report provides a detailed analysis of the market and focuses on key aspects such as leading companies, technology types, and leading product applications. Besides this, the report offers insights into the market trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth and advancement of the market in recent years.

Report Scope & Segmentation